Fact checked by Nick Blackmer By 2060, nearly 14 million Americans may be living with Alzheimer’s disease. We still don’t ...

The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

Dr. Anelyssa D'Abreu, an associate professor of neurology in UVA's School of Medicine who specializes in geriatric neurology, ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

Repurposing existing drugs, including antibiotics, antivirals, and vaccines, may offer a promising strategy for combating ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...